Cme (CME) Shares Outstanding (Weighted Average) (2009 - 2026)

Cme (CME) has 18 years of Shares Outstanding (Weighted Average) data on file, last reported at $359.3 million in Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $359.3 million, changed 0.08% year-over-year; the trailing twelve-month figure through Mar 2026 was $359.3 million (changed 0.08% YoY), and the FY2025 annual result was $359.6 million, changed 0.07% from the prior year.
• Shares Outstanding (Weighted Average) held at $359.3 million in Q1 2026 per CME's latest filing, from $359.6 million in the prior quarter.
• Over five years, Shares Outstanding (Weighted Average) peaked at $359.7 million in Q3 2025 and troughed at $358.6 million in Q1 2022.
• A 5-year average of $359.2 million and a median of $359.3 million in 2024 frame the typical range for Shares Outstanding (Weighted Average).
• The sharpest annual moves came in 2022 and 2026: Shares Outstanding (Weighted Average) increased 0.13% in 2022, then fell 0.08% in 2026.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $358.7 million in 2022, then increased by 0.09% to $359.0 million in 2023, then climbed by 0.1% to $359.4 million in 2024, then grew by 0.07% to $359.6 million in 2025, then decreased by 0.09% to $359.3 million in 2026.
• Business Quant data shows CME's Shares Outstanding (Weighted Average) at $359.3 million in Q1 2026, $359.6 million in Q4 2025, and $359.7 million in Q3 2025.